NET PROFIT (x1000 SEK)
EMPLOYEES
Magle Biopolymers A/S
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-41,964
|
6,862
|
15,542 |
| Total assets |
509,083
|
535,861
|
515,660 |
| Current assets |
131,071
|
145,545
|
115,331 |
| Current liabilities |
224,869
|
134,099
|
105,947 |
| Equity capital |
239,341
|
279,758
|
275,770 |
| - share capital |
5,389
|
5,211
|
5,238 |
| Employees (average) |
75
|
75
|
75 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
47.0%
|
52.2%
|
53.5% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
58.3%
|
108.5%
|
108.9% |
| Return on equity (ROE) |
-17.5%
|
2.5%
|
5.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.